These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9935138)

  • 1. Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation.
    Fanchin R; Righini C; Olivennes F; Taieb J; de Ziegler D; Frydman R
    Fertil Steril; 1999 Jan; 71(1):174-81. PubMed ID: 9935138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer.
    Fanchin R; Righini C; Ayoubi JM; Olivennes F; de Ziegler D; Frydman R
    Fertil Steril; 2000 Aug; 74(2):274-81. PubMed ID: 10927044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy.
    Fanchin R; Righini C; Olivennes F; Ferreira AL; de Ziegler D; Frydman R
    Fertil Steril; 1997 Nov; 68(5):799-805. PubMed ID: 9389805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation.
    Kolb BA; Paulson RJ
    Am J Obstet Gynecol; 1997 Jun; 176(6):1262-7; discussion 1267-9. PubMed ID: 9215183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization.
    Fanchin R; Righini C; Olivennes F; Taieb J; de Ziegler D; Frydman R
    Fertil Steril; 1997 Jan; 67(1):115-9. PubMed ID: 8986694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
    Bermejo A; Cerrillo M; Ruiz-Alonso M; Blesa D; Simón C; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2014 Jan; 101(1):138-146.e3. PubMed ID: 24182413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation.
    Fanchin R; de Ziegler D; Taieb J; Olivennes F; Castracane VD; Frydman R
    Fertil Steril; 2000 Feb; 73(2):275-9. PubMed ID: 10685528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiopathology of premature progesterone elevation.
    Fanchin R; de Ziegler D; Castracane VD; Taieb J; Olivennes F; Frydman R
    Fertil Steril; 1995 Oct; 64(4):796-801. PubMed ID: 7672153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation.
    Frydman R; Cornel C; de Ziegler D; Taieb J; Spitz IM; Bouchard P
    Fertil Steril; 1991 Nov; 56(5):923-7. PubMed ID: 1936328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of endometrial echo pattern transformation after hCG trigger in predicting IVF pregnancy outcome: a prospective cohort study.
    Hou Z; Zhang Q; Zhao J; Xu A; He A; Huang X; Xie S; Fu J; Xiao L; Li Y
    Reprod Biol Endocrinol; 2019 Sep; 17(1):74. PubMed ID: 31488148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture.
    Fanchin R; Hourvitz A; Olivennes F; Taieb J; Hazout A; Frydman R
    Fertil Steril; 1997 Oct; 68(4):648-52. PubMed ID: 9341604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix.
    Albano C; Grimbizis G; Smitz J; Riethmüller-Winzen H; Reissmann T; Van Steirteghem A; Devroey P
    Fertil Steril; 1998 Aug; 70(2):357-9. PubMed ID: 9696235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.